Overview
Qing Shi practices in Shanghai, China. Ms. Shi is rated as an Advanced expert by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Prostate Cancer.
Her clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 15 articles in the study of Diffuse Large B-Cell Lymphoma (DLBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMs. Shi isAdvanced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaMs. Shi isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Batten DiseaseMs. Shi isExperienced. Learn about Batten Disease.
- CLN1 DiseaseMs. Shi isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseMs. Shi isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseMs. Shi isExperienced. Learn about CLN3 Disease.
- CLN4 DiseaseMs. Shi isExperienced. Learn about CLN4 Disease.
- CLN5 DiseaseMs. Shi isExperienced. Learn about CLN5 Disease.